AI-Native Life Sciences & Clinical Trial Platforms Market Size, Statistics, Growth Trend Analysis and Forecast Report, 2026–2036

The AI-Native Life Sciences & Clinical Trial Platforms market is segmented By Application (Patient Recruitment & Retention, Trial Design & Protocol Optimization, Site Selection & Feasibility, Clinical Operations Automation & Safety Monitoring, Real-World Evidence Integration, Regulatory Submission Automation), By Technology (Machine Learning, Natural Language Processing, Predictive Analytics, Computer Vision (imaging-based endpoint analysis)), By Deployment (Cloud-Based, On-Premises, Hybrid), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic Medical Centers), By Therapeutic Area (Oncology, Rare Disease, Cardiology, Neurology, Infectious Disease, Other Therapeutic Areas), and By Trial Phase (Phase I, Phase II, Phase III, Phase IV / Post-Market Surveillance).